Clinical Trials in Pozzilli, Isernia
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Multiple Sclerosis
Sanofi900 enrolled338 locationsNCT06141486
Recruiting
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease
Parkinson Disease
AbbVie270 enrolled19 locationsNCT06965374
Recruiting
Not Applicable
Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)
Atrial FibrillationAtrial Fibrillation (Paroxysmal)
Hospital Universitario 12 de Octubre440 enrolled17 locationsNCT06698159
Recruiting
Not Applicable
Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis
Progressive Multiple Sclerosis
Neuromed IRCCS40 enrolled1 locationNCT05811013
Recruiting
Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis
Neuromed IRCCS150 enrolled1 locationNCT04121065
Recruiting
Not Applicable
miR-142-3p as Potential Biomarker of Synaptopathy in MS
Multiple SclerosisSpasticity
Neuromed IRCCS1,000 enrolled1 locationNCT03999788
Recruiting
Not Applicable
Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy in MS
Patient Participation
Neuromed IRCCS100 enrolled1 locationNCT05779449
Recruiting
Biomarkers of Synaptic Damage in Multiple Sclerosis
Amyotrophic Lateral SclerosisMultiple SclerosisAlzheimer Disease+1 more
Neuromed IRCCS300 enrolled1 locationNCT03217396